Akebia Therapeutics (AKBA) Misses Q4 EPS by 32c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- Nasdaq ends higher as AI heavyweights rebound ahead of midterm results
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
| AKEBIA THERAPEUTICS (NASDAQ: AKBA) | Delayed: 0.73 +0.02 (2.82%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.71 | 52 Week High | $13.20 | |||
| Open | $0.72 | 52 Week Low | $7.00 | |||
| Day High | $0.75 | P/E | N/A | |||
| Day Low | $0.71 | EPS | $0.00 | |||
| Volume | 6,175,125 | |||||
